Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials-Reference-Cited by-同舟云学术

Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials

Published:2021-11-22 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Chakraborty Rabindra Nath,Langade Deepak,More Shyam,Revandlkar Vaibhav,Birla Ashish

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference55 articles.

1. 2018 Chinese Guidelines for prevention and treatment of hypertension: A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension;J Geriatr Cardiol,2019

2. A two-for-one bargain: using cilnidipine to treat hypertension and its comorbidities;Iyer RP;J Clin Hypertens (Greenwich),2013

3. Hypertensive and cardiovascular profiles of a newly synthesized dihydropyridine derivative 2-methoxyethyl (E)-3-phenyl-2-propen-1-yl(6)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate (FRC-8653);Ikeda K;Pharmacometrics,1992

4. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension;Kishi T;Clin Exp Hypertens,2009

5. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats;Hosono M;Jpn J Pharmacol,1995

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EFFECTS OF METOPROLOL ON VASCULAR FUNCTION, VASCULAR ENDOTHELIAL FUNCTION FACTOR AND RHOA PROTEIN FACTOR ACTIVITY IN SPONTANEOUSLY HYPERTENSIVE RATS;ACTA MEDICA MEDITERR;2022